Parnell is a fully integrated pharmaceutical company operating in animal and human health, with significant contract manufacturing operations. Our modern facility based in Sydney, Australia has FDA and EMA approvals (and others) to manufacture sterile injectable human and veterinary products, as well as medicated chews for pets. Our full array of development and manufacturing capabilities, coupled with our flexible operations means we can deliver all your manufacturing project needs.

476 Gardeners Road
Unit 4
Alexandria, NSW 2015
Tel: +1 (913) 274-2126

PharmTech News Articles

FDA issued a warning letter to Cixi Zhixin Bird Clean-Care Product Co., Ltd for violations of cGMP for finished pharmaceuticals.

The company announced an investment in a new facility in Dundalk, County Louth, Ireland.

Pharmco Laboratories received an FDA warning letter for significant violations of CGMP for finished drugs and APIs at its Florida, US facility as well as misbranding of over-the-counter (OTC) acne and sunscreen drug products.

Novo Nordisk entered a research collaboration with the University of Oxford focused on Type 2 diabetes.